Diabetes mellitus: A predictor for late radiation morbidity

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 3, 1999, Pages 475-479

  Herold, David M ^a   Hanlon, Alexandra L ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

3DCRT; Diabetes; Morbidity; Prostate cancer; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; DIABETES MELLITUS; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIVITY; RISK ASSESSMENT; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DIABETES COMPLICATIONS; DIGESTIVE SYSTEM; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TIME FACTORS; UROGENITAL SYSTEM;

EID: 0032972201     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00460-X     Document Type: Article

References (29)

1. Isselbacher K., Braunwald E., Wilson J., et al. Harrison's principles of internal medicine. 13th ed. 1994;McGraw Hill, New York.
2. Burgos L. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology. 70:1989;591-597.
3. Meyer J. Diabetes and wound healing. Crit Care Nurs Clin North Am. 8:1996;195-201.
4. Morain D., Colen L. Wound dealing in diabetes mellitus. Clin Plast Surg. 17:1990;493-501.
5. Peters A., Kerner W. Perioperative management of the diabetic patient. Exp Clin Endocrinol. 103:1995;213-218.
6. Perez C., Hanks G., Leibel S., et al. Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Int J Radiat Oncol Biol Phys. 72:1993;56-73.
7. Hanks G.E. Optimizing the radiation treatment and outcome of prostate cancer. Int J Radiat Oncol Biol Phys. 11:1985;1235-1245.
8. Hanks G.E., Leibel S., Krall J.M., et al. Dose response observations for local control of adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 11:1985;153-157.
9. Hanks G.E., Schultheiss T.E., Hanlon A.L., et al. Optimization of conformal radiation treatment of prostate cancer. Report of a dose escalation study. Int J Radiat Oncol Biol Phys. 37:1997;543-550.
10. Hanks G, Schultheiss T, Hunt M. Clinical experience with 3D radiotherapy treating prostate cancer. Proceedings of the International Symposium on 3D Radiation Therapy of Prostate Cancer; 1993.
11. Leibel S. Three-dimensional conformal radiotherapy in localized carcinoma of the prostate Interim report of a phase I dose-escalation study . Int J Radiat Oncol Biol Phys. 152:1994;1792-1798.
12. Sandler H.M., McLaughlin P.W., Haken R.T., et al. Results of 3D conformal radiotherapy in the treatment of 707 patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 32:1995;141.
13. Hanks G., Lee W., Hanlon A., et al. Conformal technique dose-escalation in prostate cancer Improved cancer control with higher doses in patients with pretreatment PSA > 10 ngm/ml . Int J Radiat Oncol Biol Phys. 35:1996;861-868.
14. Lee W., Hanks G., Hanlon A., et al. Lateral shielding reduces rectal morbidity following high-dose 3D conformal radiotherapy for clinically localized prostate cancer Further evidence for a significant dose effect . Int J Radiat Oncol Biol Phys. 35:1996;251-257.
15. Hanlon A., Schultheiss T., Hunt M., et al. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys. 38:1997;59-63.
16. Schultheiss T., Lee W., Hunt M., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;3-11.
17. Boersma L., vandenBrink M., Bruce A., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92.
18. Hartford A., Niemierko A., Adams J., et al. Conformal irradiation of the prostate Estimating long-term rectal bleeding using dose-volume histograms . Int J Radiat Oncol Biol Phys. 36:1996;221-230.
19. ICRU. ICRU Report No. 50. International commission on radiation units and measurements: prescribing, recording, and reporting photon beam therapy. International Conference on Radiation Units and Measurements 1993, Washington, DC.
20. Cox J., Stetz B., Pajak T. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
21. Schultheiss T.E., Hanks G.E., Hunt M.A., et al. Incidence and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys. 32:1995;643-650.
22. Teshima T., Hanks G., Hanlon A., et al. Rectal bleeding after conformal 3D treatment of prostate cancer Time to occurrence, response to treatment and duration of morbidity . Int J Radiat Oncol Biol Phys. 39:1997;77-83.
23. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc. 53:1958;447-457.
24. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
25. Cox D. Regression methods and life tables (with discussion). J Statist Soc. 34:1972;187-220.
26. Peto R., Pike M., Armitage P. Design and analysis of randomized trials required prolonged observation of each patient, II. Analysis and examples. Br J Cancer. 35:1977;1-39.
27. Schwartz S., Schwartz J. Management of diabetes mellitus. 3rd ed. 1993;Essential Medical Information Systems, Inc, San Antonio.
28. Maruyama Y. Jr, Utley J., Vider M., et al. Radiation and small bowel complications in cervical carcinoma therapy. Radiology. 112:1974;699-703.
29. VanNagell J.P. Jr, Maruyama Y., Utley J., et al. Bladder or rectal injury following radiation therapy for cervical cancer. Am J Obstet Gynecol. 119:1974;6:727-6:732.